Previous Close | 249.40 |
Open | 250.39 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's Range | 249.98 - 252.92 |
52 Week Range | 182.09 - 259.00 |
Volume | |
Avg. Volume | 2,678,988 |
Market Cap | 186.013B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | 44.43 |
EPS (TTM) | 5.66 |
Earnings Date | Apr 23, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | 1.08 (0.43%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 260.70 |
Subscribe to Yahoo Finance Plus to view Fair Value for DHR
The latest trading day saw Danaher (DHR) settling at $251.47, representing a +0.83% change from its previous close.
Danaher (DHR) gains from strength in academic and life science research markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology and Diagnostics units is concerning.
Danaher (DHR) reachead $253.10 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close.